Luca Pagliaro

7PUBLICATIONS
62CO-AUTHORS
Molecular targetsHaematological tumoursNeonatologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 19, 2026
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

|Mar 06, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Danika Di Giacomo, Petri Pölönen, Valentina Bardelli

|Jun 26, 2025
Genetics of Darier's Disease: New Insights into Pathogenic Mechanisms.

Barbara Moschella, Sabrina Busciglio, Enrico Ambrosini

|Apr 17, 2025
Nidogen-1, a Player in KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.

Jolien Vanhooren, Larissa Deneweth, Luca Pagliaro

|Jun 13, 2024
Acute lymphoblastic leukaemia.

Luca Pagliaro, Sai-Juan Chen, Daniel Herranz

|Jun 04, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Matteo Marchesini, Andrea Gherli, Elisa Simoncini

Pageof 2

Frequent Collaborators

4 joint publications

Mariateresa Giaimo

4 joint publications

Cristina Mecucci

3 joint publications

Raffaella Zamponi

3 joint publications

Elisa Simoncini